Reimportation Likely In 2003, Merck Says, But HHS Certification Should Stay
Executive Summary
Merck expects Congress to pass reimportation legislation in 2003 but to retain the requirement that HHS certify the safety of the program before it is implemented
You may also be interested in...
Rx Imports: Pfizer Says Political Bark Is Worse Than Commercial Bite
The impact of Canadian imports on Pfizer's U.S. pharmaceutical business represents less than two-tenths of one percent of sales, the company indicated during an Oct. 22 conference call
Rx Imports: Pfizer Says Political Bark Is Worse Than Commercial Bite
The impact of Canadian imports on Pfizer's U.S. pharmaceutical business represents less than two-tenths of one percent of sales, the company indicated during an Oct. 22 conference call
Reimportation In North America Is Inevitable, Roche Suggests; EU Is Model
A U.S./Canada pharmaceutical importation system may be inevitable, Roche Global Pharmaceutical Head William Burns suggested during an Oct. 16 investor conference call
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: